These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome. Tanaka M; Kanamori H; Yamaji S; Mishima A; Fujita H; Fujisawa S; Murata T; Koharazawa H; Matsuzaki M; Mohri H Anticancer Drugs; 1999 Mar; 10(3):289-91. PubMed ID: 10327034 [TBL] [Abstract][Full Text] [Related]
8. Low-dose cytosine arabinoside in patients with acute myeloblastic leukemia and myelodysplastic syndrome. Heyll A; Aul C; Heyll U; Schneider W Haematol Blood Transfus; 1987; 30():322-5. PubMed ID: 3476364 [No Abstract] [Full Text] [Related]
9. [Treatment of myelodysplastic syndrome using continual subcutaneous infusion of low doses of cytosine arabinoside]. Vozobulová V; Koza V; Cepelák V; Neuwirtová R; Masek Z Vnitr Lek; 1990 May; 36(5):483-8. PubMed ID: 2375080 [TBL] [Abstract][Full Text] [Related]
10. Low dose cytosine arabinoside in the treatment of the primary myelodysplastic syndrome. Pluta A; Kowalewski J; Kurowska M; Spiewak H; Hus M Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):787-91. PubMed ID: 1713883 [TBL] [Abstract][Full Text] [Related]
11. Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes. Murray M; Sarsfield P; Lawlor E; McCann SR Ir J Med Sci; 1988 Jul; 157(7):238-41. PubMed ID: 3170148 [No Abstract] [Full Text] [Related]
12. Bilateral Acute Anterior Uveitis during Chemotherapy with Cytosine Arabinoside with a Total Cumulative Dose of 24 000 mg for Myelodysplastic Syndrome. Häller CNI; Sadeghi Y; Benmachiche M; Guex-Crosier Y Klin Monbl Augenheilkd; 2020 Apr; 237(4):425-426. PubMed ID: 32330986 [No Abstract] [Full Text] [Related]
13. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute myelogenous leukemia. Maiolo AT; Foa P; Cortellaro M; Lambertenghi-Deliliers G; Colantoni A; Cesana B; Castoldi GL; Cazzola M; Giordano M; Riccardi A Haematologica; 1987; 72(1):61-5. PubMed ID: 3108098 [No Abstract] [Full Text] [Related]
14. Efficacy of low-dose cytarabine therapy in myelodysplastic syndromes. el-Mangoush M; Singh NK J Assoc Physicians India; 1992 Jul; 40(7):452-4. PubMed ID: 1484026 [TBL] [Abstract][Full Text] [Related]
20. Response of a case of myelodysplastic syndrome with partial myeloperoxidase deficiency to continuous infusion of low-dose cytosine arabinoside. Cheong SK Singapore Med J; 1987 Dec; 28(6):577-8. PubMed ID: 2831627 [No Abstract] [Full Text] [Related] [Next] [New Search]